You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 39 No. 7, July 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Negative Symptoms in Schizophrenia

Definition and Reliability

Nancy C. Andreasen, MD, PhD

Arch Gen Psychiatry. 1982;39(7):784-788.


Abstract

• Recently, a renaissance of interest in "negative symptoms," eg, affective flattening or impoverishment of speech and language, has occurred. Although some investigators believe that these symptoms are important indicators of outcome, of response to treatment, and perhaps of a distinct, underlying pathologic process, research on the negative-symptom syndrome in schizophrenia has been handicapped because no standard instrument existed to assess it. This investigation reports on the developed Scale for the Assessment of Negative Symptoms. When symptoms are defined by objective behavioral indices, they have excellent interrater reliability. Furthermore, the five symptom complexes defined by the scale (affective flattening, alogia, avolition, anhedonia, and attentional impairment) have good internal consistency, which indicates that the conceptual organization of the scale is also cohesive.



Author Affiliations

From the Department of Psychiatry, University of Iowa, Iowa City.


Footnotes

Accepted for publication Feb 11, 1982.

Reprint requests to Department of Psychiatry, University of Iowa, Iowa City, IA 52242 (Dr Andreasen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antecedents and Patterns of Suicide Behavior in First-Admission Psychosis
Bakst et al.
Schizophr Bull 2009;0:sbp001v1-sbp001.
ABSTRACT | FULL TEXT  

Is the incidence of psychotic disorder in decline? Epidemiological evidence from two decades of research
Kirkbride et al.
Int J Epidemiol 2008;0:dyn168v1-dyn168.
ABSTRACT | FULL TEXT  

Initial Phase 2 Trial of a Nicotinic Agonist in Schizophrenia
Freedman et al.
Am. J. Psychiatry 2008;165:1040-1047.
ABSTRACT | FULL TEXT  

Negative Symptoms in Schizophrenia: Avolition and Occam's Razor
Foussias and Remington
Schizophr Bull 2008;0:sbn094v1-sbn094.
ABSTRACT | FULL TEXT  

Reasoning Anomalies Associated With Delusions in Schizophrenia
Langdon et al.
Schizophr Bull 2008;0:sbn069v1-sbn069.
ABSTRACT | FULL TEXT  

Studying and Treating Schizophrenia Using Virtual Reality: A New Paradigm
Freeman
Schizophr Bull 2008;34:605-610.
ABSTRACT | FULL TEXT  

Theory of Mind and Schizophrenia: A Positron Emission Tomography Study of Medication-Free Patients
Andreasen et al.
Schizophr Bull 2008;34:708-719.
ABSTRACT | FULL TEXT  

Mental state decoding v. mental state reasoning as a mediator between cognitive and social function in psychosis
McGlade et al.
Br. J. Psychiatry 2008;193:77-78.
ABSTRACT | FULL TEXT  

Taking the Perspective of the Other Contributes to Awareness of Illness in Schizophrenia
Langdon and Ward
Schizophr Bull 2008;0:sbn039v2-sbn039.
ABSTRACT | FULL TEXT  

Galantamine for the Treatment of Cognitive Impairments in People With Schizophrenia
Buchanan et al.
Am. J. Psychiatry 2008;165:82-89.
ABSTRACT | FULL TEXT  

The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): The Efficacy of Glutamatergic Agents for Negative Symptoms and Cognitive Impairments
Buchanan et al.
Am. J. Psychiatry 2007;164:1593-1602.
ABSTRACT | FULL TEXT  

Cognitive Improvement After Treatment With Second-Generation Antipsychotic Medications in First-Episode Schizophrenia: Is It a Practice Effect?
Goldberg et al.
Arch Gen Psychiatry 2007;64:1115-1122.
ABSTRACT | FULL TEXT  

Adjunctive Treatment With a Dopamine Partial Agonist, Aripiprazole, for Antipsychotic-Induced Hyperprolactinemia: A Placebo-Controlled Trial
Shim et al.
Am. J. Psychiatry 2007;164:1404-1410.
ABSTRACT | FULL TEXT  

Identifying Unmet Therapeutic Domains in Schizophrenia Patients: The Early Contributions of Wayne Fenton From Chestnut Lodge
McGlashan and Carpenter
Schizophr Bull 2007;33:1086-1092.
ABSTRACT | FULL TEXT  

Symptom rating scales and outcome in schizophrenia
Mortimer
Br. J. Psychiatry 2007;191:s7-s14.
ABSTRACT | FULL TEXT  

Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: an attempt for modelling some symptoms of psychosis in man
Boeijinga et al.
J Psychopharmacol 2007;21:321-337.
ABSTRACT  

Asperger Syndrome and Medication Treatment
Tsai
Focus Autism Other Dev Disabl 2007;22:138-148.
ABSTRACT  

Psychological effects of ketamine in healthy volunteers: Phenomenological study
Pomarol-Clotet et al.
Br. J. Psychiatry 2006;189:173-179.
ABSTRACT | FULL TEXT  

Food and Drug Administration Perspective on Negative Symptoms in Schizophrenia as a Target for a Drug Treatment Claim
Laughren and Levin
Schizophr Bull 2006;32:220-222.
ABSTRACT | FULL TEXT  

Anhedonia in Schizophrenia: A Review of Assessment Strategies
Horan et al.
Schizophr Bull 2006;32:259-273.
ABSTRACT | FULL TEXT  

The Structure of Negative Symptoms Within Schizophrenia: Implications for Assessment
Blanchard and Cohen
Schizophr Bull 2006;32:238-245.
ABSTRACT | FULL TEXT  

Data Gathering: Biased in Psychosis?
Van Dael et al.
Schizophr Bull 2006;32:341-351.
ABSTRACT | FULL TEXT  

An Industry Perspective on the NIMH Consensus Statement on Negative Symptoms
Alphs
Schizophr Bull 2006;32:225-230.
ABSTRACT | FULL TEXT  

The NIMH-MATRICS Consensus Statement on Negative Symptoms
Kirkpatrick et al.
Schizophr Bull 2006;32:214-219.
FULL TEXT  

Treatment of Schizophrenia Negative Symptoms: Future Prospects
Erhart et al.
Schizophr Bull 2006;32:234-237.
ABSTRACT | FULL TEXT  

Long-Term Course of Adolescent Schizophrenia
Fleischhaker et al.
Schizophr Bull 2005;31:769-780.
ABSTRACT | FULL TEXT  

Special Section on the GAF: Selection of Outcome Assessment Instruments for Inpatients With Severe and Persistent Mental Illness
Burlingame et al.
Psychiatr. Serv. 2005;56:444-451.
ABSTRACT | FULL TEXT  

Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
Andreasen et al.
Am. J. Psychiatry 2005;162:441-449.
ABSTRACT | FULL TEXT  

Incidence of bipolar affective disorder in three UK cities: Results from the AeSOP study
LLOYD et al.
Br. J. Psychiatry 2005;186:126-131.
ABSTRACT | FULL TEXT  

Facial Expressiveness in Patients With Schizophrenia Compared to Depressed Patients and Nonpatient Comparison Subjects
Tremeau et al.
Am. J. Psychiatry 2005;162:92-101.
ABSTRACT | FULL TEXT  

Olanzapine Treatment of Residual Positive and Negative Symptoms
Buchanan et al.
Am. J. Psychiatry 2005;162:124-129.
ABSTRACT | FULL TEXT  

Acute and transient psychotic disorders: precursors, epidemiology, course and outcome
Singh et al.
Br. J. Psychiatry 2004;185:452-459.
ABSTRACT | FULL TEXT  

Cumulative incidence of mental disorders among offspring of mothers with psychotic disorder: Results from the Helsinki High-Risk Study
Niemi et al.
Br. J. Psychiatry 2004;185:11-17.
ABSTRACT | FULL TEXT  

Schizophrenia and Other Psychotic Disorders
Jibson et al.
Focus 2004;2:17-30.
ABSTRACT | FULL TEXT  

Apathy in Schizophrenia: Reduced Frontal Lobe Volume and Neuropsychological Deficits
Roth et al.
Am. J. Psychiatry 2004;161:157-159.
ABSTRACT | FULL TEXT  

Monitoring and Care of Young People at Incipient Risk of Psychosis
Yung et al.
Focus 2004;2:158-174.
ABSTRACT | FULL TEXT  

Inferior Frontal White Matter Anisotropy and Negative Symptoms of Schizophrenia: A Diffusion Tensor Imaging Study
Wolkin et al.
Am. J. Psychiatry 2003;160:572-574.
ABSTRACT | FULL TEXT  

A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia
Mulholland et al.
J Psychopharmacol 2003;17:107-112.
ABSTRACT  

Randomized Controlled Trial of Interventions Designed to Reduce the Risk of Progression to First-Episode Psychosis in a Clinical Sample With Subthreshold Symptoms
McGorry et al.
Arch Gen Psychiatry 2002;59:921-928.
ABSTRACT | FULL TEXT  

Rehab Rounds: A Service Response to Prolonged Recovery in Early Psychosis
Edwards et al.
Psychiatr. Serv. 2002;53:1067-1069.
ABSTRACT | FULL TEXT  

Visual Perceptual and Working Memory Impairments in Schizophrenia
Tek et al.
Arch Gen Psychiatry 2002;59:146-153.
ABSTRACT | FULL TEXT  

Disturbed Facial Affect Recognition in Patients With Schizophrenia Associated With Hypoactivity in Distributed Brain Regions: A Magnetoencephalographic Study
Streit et al.
Am. J. Psychiatry 2001;158:1429-1436.
ABSTRACT | FULL TEXT  

Neural Correlates of Formal Thought Disorder in Schizophrenia: Preliminary Findings From a Functional Magnetic Resonance Imaging Study
Kircher et al.
Arch Gen Psychiatry 2001;58:769-774.
ABSTRACT | FULL TEXT  

Neural Mechanisms of Anhedonia in Schizophrenia: A PET Study of Response to Unpleasant and Pleasant Odors
Crespo-Facorro et al.
JAMA 2001;286:427-435.
ABSTRACT | FULL TEXT  

Relationship Between Positive and Negative Symptoms of Schizophrenia and Schizotypal Symptoms in Nonpsychotic Relatives
Fanous et al.
Arch Gen Psychiatry 2001;58:669-673.
ABSTRACT | FULL TEXT  

Patterns and predictors of hospitalisation in first-episode psychosis: Prospective cohort study
SIPOS et al.
Br. J. Psychiatry 2001;178:518-523.
ABSTRACT | FULL TEXT  

Six-Month Outcomes for Patients Who Switched to Olanzapine Treatment
Noordsy et al.
Psychiatr. Serv. 2001;52:501-507.
ABSTRACT | FULL TEXT  

A Separate Disease Within the Syndrome of Schizophrenia
Kirkpatrick et al.
Arch Gen Psychiatry 2001;58:165-171.
ABSTRACT | FULL TEXT  

Effectiveness of an Attention- and Memory-Training Program on Neuropsychological Deficits in Schizophrenia
Kurtz et al.
Neurorehabil Neural Repair 2001;15:75-80.
ABSTRACT  

Cognitive approach to depression and suicidal thinking in psychosis: I. Ontogeny of post-psychotic depression
BIRCHWOOD et al.
Br. J. Psychiatry 2000;177:516-528.
ABSTRACT | FULL TEXT  

Cognitive approach to depression and suicidal thinking in psychosis: 2. Testing the validity of a social ranking model
BIRCHWOOD et al.
Br. J. Psychiatry 2000;177:522-528.
ABSTRACT | FULL TEXT  

Clozapine Treatment of Outpatients With Schizophrenia: Outcome and Long-Term Response Patterns
Breier et al.
Psychiatr. Serv. 2000;51:1249-1253.
FULL TEXT  

Volumetric Measure of the Frontal and Temporal Lobe Regions in Schizophrenia: Relationship to Negative Symptoms
Sanfilipo et al.
Arch Gen Psychiatry 2000;57:471-480.
ABSTRACT | FULL TEXT  

Use of Community Support Services by Middle-Aged and Older Patients With Psychotic Disorders
Shaw et al.
Psychiatr. Serv. 2000;51:506-512.
ABSTRACT | FULL TEXT  

Three-year outcome of first-episode psychoses in an established community psychiatric service
SINGH et al.
Br. J. Psychiatry 2000;176:210-216.
ABSTRACT | FULL TEXT  

Depressive Symptoms in Schizophrenia
Zisook et al.
Am. J. Psychiatry 1999;156:1736-1743.
ABSTRACT | FULL TEXT  

Empirical Validation of Primary Negative Symptoms: Independence From Effects of Medication and Psychosis
Kelley et al.
Am. J. Psychiatry 1999;156:406-411.
ABSTRACT | FULL TEXT  

From Pleasure to Anhedonia: Forbidden Desires and the Construction of Schizophrenia
Heinz and Heinze
Theory Psychology 1999;9:47-65.
ABSTRACT  

Clozapine and Risperidone in Chronic Schizophrenia: Effects on Symptoms, Parkinsonian Side Effects, and Neuroendocrine Response
Breier et al.
Am. J. Psychiatry 1999;156:294-298.
ABSTRACT | FULL TEXT  

Reduced Central Serotonin Transporters in Alcoholism
Heinz et al.
Am. J. Psychiatry 1998;155:1544-1549.
ABSTRACT | FULL TEXT  

Summer Birth and the Deficit Syndrome of Schizophrenia
Kirkpatrick et al.
Am. J. Psychiatry 1998;155:1221-1226.
ABSTRACT | FULL TEXT  

Apathy, Depression, and Cognitive Performance in HIV-1 Infection
Castellon et al.
J. Neuropsychiatry Clin. Neurosi. 1998;10:320-329.
ABSTRACT | FULL TEXT  

Psychopharmacological Treatment of Schizophrenia: What Social Workers Need to Know
Bentley
Research on Social Work Practice 1998;8:384-405.
ABSTRACT  

Positive and Negative Symptom Response to Clozapine in Schizophrenic Patients With and Without the Deficit Syndrome
Buchanan et al.
Am. J. Psychiatry 1998;155:751-760.
ABSTRACT | FULL TEXT  

Auditory Hallucinations and the Temporal Cortical Response to Speech in Schizophrenia: A Functional Magnetic Resonance Imaging Study
Woodruff et al.
Am. J. Psychiatry 1997;154:1676-1682.
ABSTRACT | FULL TEXT  

Recent Advances in the Understanding of Negative Symptoms in Schizophrenia
Littrell and Littrell
J Am Psychiatr Nurses Assoc 1997;3:111-117.
ABSTRACT  

Prediction of Compliance With Outpatient Referral in Patients With Schizophrenia and Psychoactive Substance Use Disorders
Miner et al.
Arch Gen Psychiatry 1997;54:706-712.
ABSTRACT  

The Relationship Between Plasma Haloperidol Concentrations and Clinical Results
Palao et al.
Arch Gen Psychiatry 1996;53:1167-1168.
ABSTRACT  

Maximizing Psychosocial Interventions
Littrell and Freeman
J Am Psychiatr Nurses Assoc 1995;1:214-218.
ABSTRACT  

Behavioral vs Biochemical Prediction of Clinical Stability Following Haloperidol Withdrawal in Schizophrenia
van Kammen et al.
Arch Gen Psychiatry 1995;52:673-678.
ABSTRACT  

Symptoms of Schizophrenia: Methods, Meanings, and Mechanisms
Andreasen et al.
Arch Gen Psychiatry 1995;52:341-351.
ABSTRACT  

A Longitudinal Study of Symptom Dimensions in Schizophrenia: Prediction and Patterns of Change
Arndt et al.
Arch Gen Psychiatry 1995;52:352-360.
ABSTRACT  

Frontostriatal Disorder of Cerebral Metabolism in Never-Medicated Schizophrenics
Buchsbaum et al.
Arch Gen Psychiatry 1992;49:935-942.
ABSTRACT  

Hypofrontality in Neuroleptic-Naive Patients and in Patients With Chronic Schizophrenia: Assessment With Xenon 133 Single-Photon Emission Computed Tomography and the Tower of London
Andreasen et al.
Arch Gen Psychiatry 1992;49:943-958.
ABSTRACT  

The Comprehensive Assessment of Symptoms and History (CASH) An Instrument for Assessing Diagnosis and Psychopathology
Andreasen et al.
Arch Gen Psychiatry 1992;49:615-623.
ABSTRACT  

Social Skills Training and Negative Symptoms
Matousek et al.
Behav Modif 1992;16:39-63.
ABSTRACT  

The Positive-Negative Distinction in Schizophrenia: Review of Natural History Validators
McGlashan and Fenton
Arch Gen Psychiatry 1992;49:63-72.
ABSTRACT  

Natural History of Schizophrenia Subtypes: II. Positive and Negative Symptoms and Long-term Course
Fenton and McGlashan
Arch Gen Psychiatry 1991;48:978-986.
ABSTRACT  

Some Cytoarchitectural Abnormalities of the Entorhinal Cortex in Schizophrenia
Arnold et al.
Arch Gen Psychiatry 1991;48:625-632.
ABSTRACT  

Fluphenazine Dose, Clinical Response, and Extrapyramidal Symptoms During Acute Treatment
Levinson et al.
Arch Gen Psychiatry 1990;47:761-768.
ABSTRACT  

Positive and Negative Symptoms in Schizophrenia: A Critical Reappraisal
Andreasen et al.
Arch Gen Psychiatry 1990;47:615-621.
ABSTRACT  

Antecedents of Predominantly Negativeand Predominantly Positive-Symptom Schizophrenia in a High-Risk Population
Cannon et al.
Arch Gen Psychiatry 1990;47:622-632.
ABSTRACT  

Norepinephrine in Acute Exacerbations of Chronic Schizophrenia: Negative Symptoms Revisited
van Kammen et al.
Arch Gen Psychiatry 1990;47:161-168.
ABSTRACT  

Alprazolam Augmentation of Antipsychotic Pharmacotherapy?-Reply
Wolkowitz et al.
Arch Gen Psychiatry 1989;46:1052-1053.
ABSTRACT  

Ventricle-Brain Ratio, Computed Tomographic Density, and Brain Area in 50 Schizophrenics
Pearlson et al.
Arch Gen Psychiatry 1989;46:690-697.
ABSTRACT  

Cholinergic Hyperactivity and Negative Schizophrenic Symptoms: A Model of Cholinergic/Dopaminergic Interactions in Schizophrenia
Tandon and Greden
Arch Gen Psychiatry 1989;46:745-753.
ABSTRACT  

Double-blind Comparison of Alprazolam, Diazepam, and Placebo for the Treatment of Negative Schizophrenic Symptoms
Csernansky et al.
Arch Gen Psychiatry 1988;45:655-659.
ABSTRACT  

Brain imaging: applications in psychiatry
Andreasen
Science 1988;239:1381-1388.
ABSTRACT  

Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger
Arch Gen Psychiatry 1987;44:660-669.
ABSTRACT  

Regional Brain Function in Schizophrenia: I. A Positron Emission Tomography Study
Gur et al.
Arch Gen Psychiatry 1987;44:119-125.
ABSTRACT  

A Longitudinal Study of Thought Disorder in Manic Patients
Harrow et al.
Arch Gen Psychiatry 1986;43:781-785.
ABSTRACT  

Structural Abnormalities in the Frontal System in Schizophrenia: A Magnetic Resonance Imaging Study
Andreasen et al.
Arch Gen Psychiatry 1986;43:136-144.
ABSTRACT  

Akathisia Variants and Tardive Dyskinesia
Barnes and Braude
Arch Gen Psychiatry 1985;42:874-878.
ABSTRACT  

Positive and Negative Symptoms and Jackson: A Conceptual History
Berrios
Arch Gen Psychiatry 1985;42:95-97.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.